Regeneron Pharmaceuticals
REGN
#232
Rank
ยฃ72.96 B
Marketcap
ยฃ705.30
Share price
0.13%
Change (1 day)
31.09%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): ยฃ35.34

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ35.88. In 2025 the company made an earnings per share (EPS) of ยฃ32.93 an increase over its 2024 EPS that were of ยฃ31.22.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ35.347.33%
2025ยฃ32.935.48%
2024ยฃ31.2210.34%
2023ยฃ28.29-8.56%
2022ยฃ30.94-47%
2021ยฃ58.38133.36%
2020ยฃ25.0269.13%
2019ยฃ14.79-14.44%
2018ยฃ17.29100.71%
2017ยฃ8.6131.78%
2016ยฃ6.5438.96%
2015ยฃ4.7072.55%
2014ยฃ2.73-17.55%
2013ยฃ3.31-44.98%
2012ยฃ6.01
2010-ยฃ0.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ4.01-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ13.27-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.51-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ1.80-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ15.13-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA